Study Stopped
Awaiting results from sub analysis to decide if study continuesé
Validation of the Rhinitis Control Scoring System (RCSS)
RCSS
Validation of a Rhinitis Control Tool : the Rhinitis Control Scoring System (RCSS)
1 other identifier
interventional
50
1 country
1
Brief Summary
Many patients suffering from allergic rhinitis do not recognize or perceive their symptoms. Instruments have been developed to assess quality of life in rhinitis, asthma or both, but there is a need to develop validated tools or methods to assess rhinitis control among rhinitis and/or asthmatic patients. The aim of this study is to assess the discriminative and evaluative properties of the RCSS in asthmatic patients with allergic rhinitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started Mar 2009
Longer than P75 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 26, 2009
CompletedFirst Posted
Study publicly available on registry
August 28, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedMay 27, 2013
May 1, 2013
5.3 years
August 26, 2009
May 24, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Discriminative (internal consistency, cross sectional construct validity and reliability) and evaluative (responsiveness and longitudinal construct validity) properties of the RCSS.
March to November 2009
Secondary Outcomes (1)
The relationship between rhinitis control and asthma control.
March to November 2009
Study Arms (1)
Mometasone furoate and desloratadine
OTHERMometasone and desloratadine treatment
Interventions
One month treatment with both drugs
Eligibility Criteria
You may qualify if:
- asthma
- seasonal allergic rhinitis
You may not qualify if:
- smoking
- nasal polyposis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Quebec, G1V 4G5, Canada
Related Publications (1)
Boulay ME, Boulet LP. The Rhinitis Control Scoring System: Development and validation. Am J Rhinol Allergy. 2016 Jan-Feb;30(1):54-9. doi: 10.2500/ajra.2016.30.4260.
PMID: 26867531DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louis-Philippe Boulet, MD
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professeur
Study Record Dates
First Submitted
August 26, 2009
First Posted
August 28, 2009
Study Start
March 1, 2009
Primary Completion
June 1, 2014
Study Completion
September 1, 2014
Last Updated
May 27, 2013
Record last verified: 2013-05